VFS
PPH icon

VSR Financial Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

VSR Financial Services’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$262K Buy
4,471
+103
+2% +$6K 0.04% 396
2016
Q1 		$251K Sell
4,368
-127
-3% -$7.51K 0.03% 469
2015
Q4 		$294K Sell
4,495
-22
-0.5% -$1.42K 0.03% 438
2015
Q3 		$284K Buy
+4,517
New +$317K 0.03% 433

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $3.51B AUM 13.98% 1-Year Est. Return
LFM
Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VSR Financial Services's PPH Position: Q2 2016 in Review

VSR Financial Services increased its VanEck Pharmaceutical ETF (PPH) stake by 2.4% in Q2 2016, buying an estimated $6K and bringing the position to 4,471 shares worth $262K. The position accounts for 0.04% of the portfolio, ranked #396.

VSR Financial Services first reported a position in PPH in Q3 2015 and has held it in 4 quarters since. The position peaked at $294K in Q4 2015. 58 funds tracked by Wall St. Rank hold PPH as of Q2 2016.

  • VSR Financial Services held 4,471 shares of VanEck Pharmaceutical ETF worth $262K as of Q2 2016.
  • VSR Financial Services bought 103 VanEck Pharmaceutical ETF shares in Q2 2016, an estimated $6K.
  • VanEck Pharmaceutical ETF made up 0.04% of VSR Financial Services's portfolio in Q2 2016, its #396 holding.
  • VSR Financial Services first reported a position in VanEck Pharmaceutical ETF in Q3 2015 and has held it in 4 quarters since.
  • VSR Financial Services's VanEck Pharmaceutical ETF position peaked at $294K in Q4 2015.
  • 58 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2016.

Based on VSR Financial Services's 13F filing for Q2 2016, filed 11 Aug 2016.